Evaluation of Safety and Efficacy of Qinming8631 DR Implantable Cardiac Pacemaker in Chinese Patients: A Prospective, Multicenter, Randomized Controlled Trial of the First Domestically Developed Pacemaker of China

BACKGROUND: High cost of imported pacemakers is a main obstacle for Chinese patients suffering from bradyarrhythmia, and a domestically developed pacemaker will help lower the burden. This study aimed to evaluate the safety and efficacy of Qinming8631 DR (Qinming Medical, Baoji, China), the first do...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Mei-Xiang, Wang, Dong-Qi, Xu, Jing, Zhang, Zheng, Hu, Jian-Xin, Wang, Dong-Mei, Gu, Xiang, Liu, He-Ping, Guo, Tao, Yang, Xiang-Jun, Ling, Feng, Lin, Jia-Feng, Cai, Shang-Lang, Zhu, Guo-Bin, Wang, Jian-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126155/
https://www.ncbi.nlm.nih.gov/pubmed/27823996
http://dx.doi.org/10.4103/0366-6999.193443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126155/
https://www.ncbi.nlm.nih.gov/pubmed/27823996
http://dx.doi.org/10.4103/0366-6999.193443

Ejemplares similares